WA
DYN icon

Wasatch Advisors’s Dyne Therapeutics DYN Stock Holding History

Wasatch Advisors’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.85M Hold
443,668
– – 0.06% 143
2026
Q1 		$8.04M Buy
443,668
+36,708
+9% +$633K 0.05% 135
2025
Q4 		$7.96M Sell
406,960
-116,964
-22% -$2.21M 0.05% 155
2025
Q3 		$6.63M Sell
523,924
-34,013
-6% -$388K 0.04% 173
2025
Q2 		$5.31M Buy
557,937
+46,889
+9% +$516K 0.03% 188
2025
Q1 		$5.35M Buy
511,048
+190,422
+59% +$2.72M 0.03% 184
2024
Q4 		$7.55M Sell
320,626
-3,473
-1% -$103K 0.04% 173
2024
Q3 		$11.6M Sell
324,099
-11,516
-3% -$458K 0.06% 150
2024
Q2 		$11.8M Sell
335,615
-82,179
-20% -$2.39M 0.06% 144
2024
Q1 		$11.9M Sell
417,794
-1,266,723
-75% -$28.6M 0.06% 154
2023
Q4 		$22.4M Sell
1,684,517
-3,285
-0.2% -$32.1K 0.12% 121
2023
Q3 		$15.1M Sell
1,687,802
-571,733
-25% -$6.16M 0.1% 128
2023
Q2 		$25.4M Sell
2,259,535
-667,743
-23% -$7.88M 0.15% 111
2023
Q1 		$33.7M Buy
2,927,278
+407,699
+16% +$5.29M 0.21% 92
2022
Q4 		$29.2M Buy
2,519,579
+227,311
+10% +$2.63M 0.2% 99
2022
Q3 		$29.1M Buy
+2,292,268
New +$26.3M 0.2% 106

Other funds holding DYN

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
AP
Aspect Partners Fairfax, Virginia $268M AUM 22.57% 1-Year Est. Return
AFC
Ares Financial Consulting Calabasas, California $139M AUM
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Wasatch Advisors's DYN Position: Q2 2026 in Review

Wasatch Advisors held its Dyne Therapeutics (DYN) position steady in Q2 2026 at 443,668 shares worth $9.85M. The position accounts for 0.06% of the portfolio, ranked #143.

Wasatch Advisors first reported a position in DYN in Q3 2022 and has held it in 16 quarters since. The position peaked at $33.7M in Q1 2023. 12 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Wasatch Advisors held 443,668 shares of Dyne Therapeutics worth $9.85M as of Q2 2026.
  • Wasatch Advisors left its Dyne Therapeutics share count unchanged in Q2 2026.
  • Dyne Therapeutics made up 0.06% of Wasatch Advisors's portfolio in Q2 2026, its #143 holding.
  • Wasatch Advisors first reported a position in Dyne Therapeutics in Q3 2022 and has held it in 16 quarters since.
  • Wasatch Advisors's Dyne Therapeutics position peaked at $33.7M in Q1 2023.
  • 12 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Wasatch Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.